Vulvar melanoma is a rare skin cancer that starts on the vulva, and it usually affects older adults. Early symptoms of vulvar melanoma can include a new dark spot, itching, bleeding, pain, or a sore that does not heal. It can grow and spread over time, but some cases are found early during a skin or pelvic exam. Not everyone will have the same experience. Treatment for vulvar melanoma often includes surgery, and some people also need immunotherapy, radiation, or other cancer treatment because this cancer can be life-threatening, especially if found late.
How many people live with Vulvar melanoma?
Direct counts of how many people are living with vulvar melanoma are not routinely published, so the best estimates come from broader vulvar cancer numbers: roughly 150,000-170,000 people worldwide are living within 5 years of a vulvar cancer diagnosis, based on cancer registry estimates from the Global Cancer Observatory (Global Cancer Observatory, 2022), and because melanoma makes up about 5-10% of vulvar cancers, that suggests about 7,500-17,000 people worldwide living with vulvar melanoma, although this is an estimate rather than a direct count. In the United States, roughly 20,000-25,000 people are living within 5 years of a vulvar cancer diagnosis, again based on Global Cancer Observatory estimates (Global Cancer Observatory, 2022), which suggests about 1,000-2,500 people living with vulvar melanoma in the U.S., again as an estimate rather than a direct count.
Overview
Vulvar melanomaSymptoms
Vulvar melanoma often appears as a new or changing dark spot, lump, or sore on the vulva. It may itch, bleed, hurt, or not heal. Early symptoms of vulvar melanoma can also include skin thickening or a mole changing shape or color.
Outlook and prognosis
Vulvar melanoma can be more serious than some skin melanomas because it is often found later and may spread earlier. Outlook depends mainly on stage at diagnosis, tumor thickness, and lymph node involvement. Earlier treatment usually means a better prognosis.
Causes and risk factors
The exact cause of vulvar melanoma is often unclear. Risk may be higher with older age, fair skin, a personal or family history of melanoma, certain gene changes, and a weakened immune system; unlike many skin melanomas, sun exposure is not a main risk.
Genetic influences
Genetics matter in vulvar melanoma, but most cases are not clearly inherited. Changes in genes within the tumor can help guide treatment, while a strong family history of melanoma may raise concern in some people.
Diagnosis
Vulvar melanoma is diagnosed with a pelvic exam and a biopsy of any suspicious spot. Imaging tests may check spread. Early diagnosis of vulvar melanoma often starts when a new dark, changing, bleeding, or painful area is examined.
Treatment and drugs
Treatment for vulvar melanoma usually starts with surgery to remove the cancer. Some people also need immunotherapy, targeted treatment, or radiation, depending on how far vulvar melanoma has spread. Close follow-up matters because it can come back.
Symptoms
Vulvar melanoma often shows up as a new or changing spot on the vulva, the outer part of the genitals. You might notice small changes at first, such as itching, bleeding, or a patch that looks darker or different from the surrounding skin. The early symptoms of vulvar melanoma can be easy to mistake for irritation, an ingrown hair, or a harmless mole, so changes that do not go away deserve medical attention.
A new dark, brown, black, blue, red, or skin-colored spot on the vulva can be a symptom of vulvar melanoma. It may look like a mole, but it often stands out because it is new or simply looks different from the rest of the skin.
A spot may slowly get bigger or change shape, color, or border over time. In vulvar melanoma, the edges are sometimes uneven and the color may be patchy rather than uniform.
Ongoing itching, burning, or irritation in one area can happen even when the skin change is small. What once felt effortless can start to require more energy or focus, especially if sitting, walking, or using the bathroom becomes uncomfortable.
Some people with vulvar melanoma notice soreness, tenderness, or pain in the area. This can range from mild discomfort to pain when wiping, exercising, or having sex.
How people usually first notice Vulvar melanoma?
Vulvar melanoma is often first noticed as a new dark spot, mole-like patch, or small lump on the vulva that looks different from the surrounding skin or seems to be changing over time. Many people with vulvar melanoma first seek care because of itching, irritation, tenderness, bleeding, or a sore that does not heal, especially if the area starts to grow, darken, or develop uneven borders. These early changes can be easy to miss because they may resemble common skin irritation, which is why any new or changing vulvar spot deserves a medical check.
Types of Vulvar melanoma
Vulvar melanoma can show up in a few different forms, and the differences often affect how it looks and how quickly it changes. Doctors sometimes classify the main types of vulvar melanoma by the way the cancer cells grow, which can help explain why one spot looks like a flat dark patch while another feels more like a new lump. Symptoms don’t always look the same for everyone. In general, the early symptoms of vulvar melanoma may include a new or changing spot, itching, irritation, bleeding, or a sore that does not heal.
Mucosal lentiginous
This is a common pattern in vulvar melanoma and often appears as a flat or slightly raised dark patch with uneven color or edges. Many people notice slow widening over time rather than a sudden bump. It may also cause itching, burning, or light bleeding.
Nodular
This type usually grows more as a raised bump or firm lump than as a flat patch. It can enlarge faster than other forms, and some may find it starts bleeding, ulcerating, or becoming painful sooner. Because it may stand out like a small nodule, it is sometimes noticed during washing or toileting.
Superficial spreading
This form tends to spread across the surface first, so it may look like a flat discolored area that slowly gets larger. Color can vary within the same spot, with brown, black, blue, or pink areas. For many, this can mean a lesion that seems subtle at first but keeps changing.
Amelanotic
This variation has little or no dark pigment, so it may look pink, red, or skin-colored instead of brown or black. That can make it easier to mistake for a rash, sore, wart, or irritated area. Having one type doesn’t necessarily mean you’ll develop the others.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of vulvar melanoma, a rare cancer in the tissue around the vaginal opening; unlike some other cancers, there are no well-proven steps that clearly lower risk or prevent it. What does help is not prevention but earlier detection: paying attention to a new dark spot, lump, itching, bleeding, or a sore that does not heal, and having regular pelvic exams if your clinician recommends them, since there is no standard preventive medication or screening test for people without symptoms. That can feel frustrating, but noticing changes early and getting them checked promptly may improve the chance of finding it sooner.
What genetics can tell you about symptoms
In vulvar melanoma, genetics can give doctors clues about how the tumor may behave, but they usually do not predict day-to-day symptoms very well. Certain gene changes in the melanoma cells, such as changes in KIT, NRAS, or sometimes BRAF, may be linked to how fast the cancer grows, how likely it is to spread, and which treatments might help, so they can indirectly affect how severe symptoms become or when problems appear. For most people, though, symptoms such as itching, bleeding, pain, or a changing lump are driven more by where the melanoma is, how large it is, and whether it has spread than by inherited genetics.
Causes and risk factors
Vulvar melanoma usually starts when pigment-making cells in the vulva develop gene changes over time. Some risks are written in our DNA, passed down through families. Older age and a personal or family history of melanoma can raise the risk of vulvar melanoma. Unlike many skin melanomas, sun exposure is not thought to be a main cause. No clear lifestyle habit has been shown to cause most cases.
What are the most common causes or risk factors?
Vulvar melanoma often has no clear single cause, but it is most common in older adults, especially after menopause. Risk may be higher in people with a personal or family history of melanoma and in the small number who inherit gene changes that raise melanoma risk. Unlike many skin melanomas, vulvar melanoma is usually not tied to sun exposure, and the main risk factors are still not fully understood.
Environmental and biological risk factors
Vulvar melanoma is rare, and its risk factors are not as well defined as they are for many other cancers. The main risk factors for vulvar melanoma appear to be biological, especially older age, while clear outside triggers are less certain. Doctors often group risks into internal (biological) and external (environmental). Unlike many skin melanomas, vulvar melanoma is not clearly linked to sun exposure.
Most vulvar melanoma cases are diagnosed in older adults, often after menopause. Risk rises with age, so a new or changing dark area on the vulva later in life should be checked.
Having had melanoma before can raise the chance of developing another melanoma in a different body site. That history may lead doctors to watch new pigmented changes more closely.
Some cases start in or near an existing mole or dark patch, although many appear without a known earlier spot. A lesion that changes color, size, shape, or starts bleeding needs prompt medical review.
Ultraviolet radiation is a major risk for many skin melanomas, but it has not been shown to be a main driver of vulvar melanoma. No specific outside exposure has been firmly confirmed as a common cause, so environmental risks remain less clear than biological ones.
Genetic risk factors
Most people with vulvar melanoma do not have a known inherited gene change that fully explains why it happened. It’s usually a combination of influences rather than one clear cause, and many cases are tied to DNA changes that appear only in the tumor itself. When doctors talk about genetic risk factors for vulvar melanoma, they usually separate inherited risks from gene changes found in the cancer after it starts. Family history can matter, but clear inherited causes seem to be uncommon.
Family history: Having close relatives with melanoma can suggest an inherited tendency in the family. This does not mean vulvar melanoma will definitely occur, but it can make genetic counseling worth discussing.
CDKN2A change: Inherited changes in CDKN2A are a well-known cause of some hereditary melanoma syndromes. They are uncommon in vulvar melanoma, but they may be relevant when several relatives have had melanoma or pancreatic cancer.
BAP1 change: Rare inherited changes in BAP1 can raise the chance of melanoma and certain other cancers. These changes are not a common explanation for vulvar melanoma, but they may be considered when the family history fits.
KIT mutation: Many vulvar melanomas have changes in KIT, a gene that helps control cell growth signals. These changes are usually found only in the cancer cells and are not passed down through families.
NRAS mutation: Some vulvar melanomas carry NRAS changes that tell cells to keep growing when they should slow down. In most cases, this is a tumor-acquired change rather than an inherited risk.
NF1 loss: Changes affecting NF1 can remove one of the cell's natural growth brakes. This kind of gene change is seen in some vulvar melanomas and is usually not inherited.
BRAF mutation: BRAF changes can drive some melanomas, but they are less common in vulvar melanoma than in many melanomas on sun-exposed skin. This difference can matter because the tumor's gene pattern may help guide treatment choices.
Lifestyle risk factors
Lifestyle risk factors for vulvar melanoma are much less clearly defined than they are for many other cancers. Current evidence does not show that any specific diet or exercise pattern directly causes vulvar melanoma, but some habits may still affect overall cancer risk, immune health, inflammation, and how quickly symptoms are acted on. In practice, the strongest modifiable influences are likely the same ones that shape general cancer health rather than vulvar melanoma alone.
Tobacco use may increase overall cancer risk and can impair local tissue health and immune responses. While smoking is not a firmly established direct cause of vulvar melanoma, avoiding it supports better healing and may reduce factors that can worsen cancer outcomes.
Excess body weight and long-term physical inactivity can promote chronic inflammation and poorer metabolic health. They have not been proven to directly cause vulvar melanoma, but they may contribute to worse overall health during cancer treatment and recovery.
Heavy alcohol intake can weaken general health, affect immune function, and make it harder to maintain good nutrition. Alcohol is not a confirmed specific cause of vulvar melanoma, but limiting it may help reduce broader cancer-related health risks.
No specific food pattern has been shown to directly trigger vulvar melanoma. A diet low in nutrient-dense foods may still undermine overall health and resilience, which can matter if surgery, systemic treatment, or recovery becomes necessary.
Risk prevention
Vulvar melanoma is rare, and there is no sure way to prevent it completely because the exact cause is often unclear. Prevention is about lowering risk, not eliminating it completely. For many people, the most helpful approach is noticing new vulvar changes early and keeping up with routine gynecologic care. This matters because the early symptoms of vulvar melanoma can look subtle at first, such as a dark spot, a changing mole, itching, or bleeding.
Regular gynecology visits can help spot suspicious vulvar changes before they are ignored for months. This is especially important if you have had melanoma before or have a strong family history of melanoma.
Many living with vulvar melanoma first notice a small change during washing, toileting, or getting dressed. Check for new or changing dark patches, lumps, itching, bleeding, or sores that do not heal, and have them assessed promptly.
A vulvar spot that is growing, changing color, bleeding, or becoming painful should be checked without waiting to see if it settles. Early evaluation can lead to faster testing and treatment if needed.
If a clinician sees a suspicious vulvar lesion, a small tissue sample is often the only reliable way to rule out vulvar melanoma. Asking whether a changing spot needs a biopsy can help avoid delays caused by assuming it is irritation or an infection.
Can you prevent Vulvar melanoma?
There is no sure, proven way to prevent vulvar melanoma. Unlike many other skin cancers, it is not usually linked to sun exposure, and doctors do not know of clear lifestyle changes that reliably stop it from happening. What can help is finding it early, so any new or changing dark spot, lump, itching, bleeding, or sore on the vulva should be checked by a doctor promptly.
Transmission
Vulvar melanoma is not an infection, so it cannot be caught from someone else or passed on through sex, skin contact, towels, toilet seats, or blood. Many people with vulvar melanoma worry about close contact with a partner, but this cancer is not contagious in any way.
Most cases are also not directly inherited, although a family history of melanoma can sometimes raise risk, so if you are wondering how vulvar melanoma is inherited, it is usually not passed from parent to child in a simple, predictable pattern. In short, vulvar melanoma is considered noninfectious, and care focuses on diagnosis and treatment rather than preventing spread between people.
When to test your genes
For vulvar melanoma, gene testing is usually most useful after diagnosis, especially if the cancer is advanced, has returned, or may need targeted treatment, because tumor testing can look for changes such as KIT or BRAF. Inherited gene testing may also be worth discussing if you or close relatives have had multiple melanomas, pancreatic cancer, or a strong family history of these cancers.
Diagnosis
Vulvar melanoma is usually diagnosed after a new or changing spot on the vulva is examined by a doctor. It may be found because of itching, bleeding, pain, or a dark patch that looks different from the surrounding skin, but some people have few symptoms at first. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of vulvar melanoma depends on a close exam and a small tissue sample to confirm what the cells look like.
Doctors usually begin with a careful exam of the vulva and nearby skin, often looking for a dark, irregular, raised, or bleeding area. They may also check the vagina and cervix to see whether there are any other concerning spots.
A biopsy is the main test used to confirm vulvar melanoma. A doctor removes all or part of the suspicious area and sends it to a lab, where specialists check whether melanoma cells are present and how deep the tumor extends.
The tissue sample is studied under a microscope to confirm the diagnosis and rule out other causes of pigmented or unusual vulvar lesions. This review helps measure tumor thickness and other features that guide treatment planning.
Doctors examine the groin lymph nodes because vulvar melanoma can spread there first. If the tumor is deep or otherwise high risk, your provider may suggest a sentinel lymph node procedure to look for cancer cells in the first draining node.
How is Vulvar melanoma diagnosed?
Vulvar melanoma is usually diagnosed after a clinician examines the vulva and takes a small tissue sample from any spot that looks unusual, such as a dark patch, lump, sore, or area that is changing; this is called a biopsy. A doctor who studies the sample under a microscope confirms whether it is melanoma, and if it is, imaging scans and sometimes a check of nearby lymph nodes may be used to see whether it has spread. Genetic testing is not usually needed to make the diagnosis, but tumor testing may sometimes be done later to help plan treatment.
Stages of Vulvar melanoma
Vulvar melanoma is usually described by cancer stage rather than by a set of day-to-day symptom phases. The stage tells you how deep the cancer has grown, whether it has reached nearby lymph nodes, and whether it has spread to other parts of the body. Identifying the cause is the starting point for the right care. In many people, the early symptoms of vulvar melanoma can look like a new dark spot, a changing patch of skin, itching, bleeding, or a sore that does not heal.
Stage 0
Abnormal cells are only in the top layer of skin and have not grown deeper. This is the earliest stage and is also called melanoma in situ.
Stage 1
Vulvar melanoma is only in the vulva and is relatively small and shallow. It has not spread to lymph nodes or distant parts of the body.
Stage 2
The melanoma is still only in the vulva, but it is thicker, deeper, or has surface breakdown called ulceration. Even without spread, this stage can carry a higher risk than stage 1.
Stage 3
Vulvar melanoma has spread to nearby lymph nodes, usually in the groin, or to nearby tissues. For many, this can mean treatment becomes more complex and may involve surgery plus other therapies.
Stage 4
The cancer has spread farther, such as to deeper pelvic tissues or organs like the lungs, liver, or brain. At this stage, care often focuses on controlling the disease, easing symptoms, and maintaining quality of life as much as possible.
Outlook and prognosis
Outlook for vulvar melanoma is often guarded because many cases are diagnosed at a later stage than cutaneous melanoma, when the tumor is thicker or has already spread to nearby lymph nodes. Prognosis depends mainly on stage at diagnosis, tumor thickness, ulceration, lymph node involvement, and whether the cancer can be completely removed with surgery. People with localized disease have the best chance of long-term survival, while regional or distant spread is linked to a much higher risk of recurrence and death. Reported 5-year overall survival is roughly 70% to 80% for localized disease, about 30% to 50% for regional nodal disease, and often below 20% for metastatic disease, although outcomes vary between studies. Recurrence is common, especially in the first few years after treatment, so close follow-up is important. Newer systemic therapies such as immune checkpoint inhibitors may improve outcomes for some patients with advanced vulvar melanoma, but overall mortality remains significant compared with more common skin melanomas.
Long-term effects
Vulvar melanoma can have lasting effects on health, comfort, and daily life, especially if it comes back or spreads. The long-term picture is often shaped by how deep the cancer was, whether it had reached lymph nodes, and how well it responded to treatment. Many living with vulvar melanoma do well after treatment, but close follow-up matters because this cancer can recur months or years later. People who looked back at the early symptoms of vulvar melanoma often describe changes in a mole, dark patch, itching, or bleeding that seemed easy to dismiss at first.
Vulvar melanoma can return in the same area after treatment, even when the first treatment seemed successful. This may lead to new symptoms such as a changing spot, bleeding, pain, or irritation and often means more testing or treatment.
In some people, vulvar melanoma spreads to nearby lymph nodes or to organs farther away, which can affect long-term survival. When this happens, people may develop ongoing fatigue, weight loss, pain, cough, or other symptoms depending on where the cancer has spread.
Treatment and the cancer itself can leave lasting changes in the vulvar area, including tenderness, numbness, scarring, or tightness. For many, symptoms can make sitting, walking, exercise, or wearing certain clothing less comfortable.
Many people with vulvar melanoma have long-term changes that affect intimacy, including pain with sex, dryness, or worry about how the area looks and feels. These effects can continue after treatment because of scarring, nerve irritation, or tissue loss.
How is it to live with Vulvar melanoma?
Living with vulvar melanoma can feel deeply personal and disruptive, because it affects an intimate part of the body and often brings a mix of physical symptoms, frequent medical visits, and emotional strain. Many people living with vulvar melanoma may cope with discomfort, itching, pain, changes in body image, and anxiety about treatment, sexual health, and the chance of the cancer returning. Daily life can start to revolve around appointments, recovery, and decisions about work, intimacy, and rest, while partners, family, and close friends are often affected too, as they may take on caregiving roles and share the uncertainty, worry, and practical adjustments that come with cancer care.
Treatment and drugs
Vulvar melanoma is usually treated first with surgery to remove the cancer, along with a small border of nearby tissue, and treatment may also include checking or removing nearby lymph nodes to see if it has spread. Depending on the stage and where the melanoma is located, many living with vulvar melanoma may also be offered drug treatment such as immunotherapy, which helps the immune system attack cancer cells, and sometimes targeted therapy if the tumor has certain gene changes. Radiation is not the main treatment for most people, but it can be used in some situations, such as when surgery cannot remove all of the cancer or to help lower the chance of it coming back in the same area. Treatment plans often combine several approaches. Because this is a rare cancer, care is often guided by a specialist team, and the best treatment for vulvar melanoma depends on factors like tumor size, spread, overall health, and whether it is a new cancer or has returned.
Can you cure Vulvar melanoma?
Vulvar melanoma can sometimes be cured if it is found early and removed completely, most often with surgery. If it has spread deeper, reached other parts of the body, or comes back after treatment, a full cure is less likely, but treatment can still help by controlling the cancer, slowing its growth, and easing symptoms.
Non-drug treatment
Living with vulvar melanoma often means treatment is centered on removing the cancer and protecting day-to-day comfort, mobility, and sexual health. Managing this condition often involves surgery first, with other non-drug treatments added depending on how deep the melanoma is and whether it has spread. Supportive care is also important, especially during recovery and follow-up after treatment for vulvar melanoma without drugs.
Surgery is the main non-drug treatment for vulvar melanoma and aims to remove the melanoma along with a margin of healthy tissue. Depending on the size and location, this may be a smaller operation or a wider surgery to lower the chance of cancer being left behind. For many, this can mean planning for support after vulvar melanoma surgery as sitting, walking, and toileting may be uncomfortable at first.
If the melanoma is deeper or has higher-risk features, surgery may also include checking nearby groin lymph nodes. This helps show whether the cancer has started to spread and can guide what happens next. Sometimes this is done with a targeted sentinel node procedure rather than removing many nodes.
Radiation uses high-energy beams to treat cancer cells in a focused area. It may be used when surgery cannot remove all of the melanoma, when the cancer comes back, or when lymph nodes are involved. Not every approach works the same way, and radiation is not needed for everyone with vulvar melanoma.
Recovery often includes careful wound care, pain-free positioning, and steps to reduce friction in a sensitive area. Many living with vulvar melanoma may need sitz baths, gentle cleansing, loose clothing, and time away from usual activities while healing. Pelvic floor therapy can also help if surgery leads to tightness, discomfort, or problems with bladder or bowel function.
Your genes may have an impact on how drugs work for you
For many living with vulvar melanoma, the most important genetic testing is often on the tumor itself, not on the rest of the body, because certain DNA changes in the cancer can show whether a targeted medicine is likely to help. These changes are not present in every case, so some people may benefit more from targeted treatment while others are more likely to be treated with medicines that help the immune system attack the cancer. This kind of treatment matching is one reason doctors may recommend tumor testing before choosing a drug plan.
Pharmacological treatments
Drug treatment for vulvar melanoma is most often used when the cancer has spread, cannot be fully removed with surgery, or comes back after earlier treatment. The medicines used depend on the tumor’s gene changes and how far the cancer has grown. Not everyone responds to the same medication in the same way. For many living with vulvar melanoma, treatment for advanced vulvar melanoma often starts with immunotherapy rather than standard chemotherapy.
Pembrolizumab helps the immune system recognize and attack melanoma cells more effectively. It is commonly used for vulvar melanoma that is unresectable, recurrent, or metastatic.
Nivolumab may be given alone or together with ipilimumab, another immune-based drug that boosts the immune response in a different way. The combination can work well for some people with advanced disease, but side effects are usually more frequent and can be more serious.
Nivolumab and relatlimab are sometimes used together as another immunotherapy option for advanced melanoma. This combination may be considered when doctors want strong immune treatment with a different balance of benefits and risks.
If testing shows a BRAF V600 mutation, targeted treatment may include dabrafenib with trametinib, vemurafenib with cobimetinib, or encorafenib with binimetinib. These medicines block growth signals inside the cancer and can shrink tumors quickly in some people.
Genetic influences
Hearing that genes may play a role in vulvar melanoma can be confusing, because the gene changes found in the tumor are often different from the genes you inherit from your parents. Most people with vulvar melanoma do not have a clearly inherited cause, and many of the DNA changes linked to this cancer seem to develop in the melanoma cells over time rather than being passed down through a family. Family history is one of the strongest clues to a genetic influence, so if several relatives have had melanoma, pancreatic cancer, or certain rare cancers, your doctor may talk with you about inherited risk. In the tumor itself, doctors may look for changes in genes such as KIT, NRAS, or, less often, BRAF, because these can help explain how the cancer grew and may sometimes affect treatment choices. This means genetic testing in vulvar melanoma can refer either to blood or saliva testing for inherited risk, or to tumor testing for changes found only in the cancer. For many living with vulvar melanoma, the main point is that genes can matter, but inherited genetic risk factors for vulvar melanoma are less clearly defined than the tumor gene changes doctors can test for.
Is Vulvar melanoma genetic?
Genetics matter in vulvar melanoma, but most cases are not clearly inherited. Changes in genes within the tumor can help guide treatment, while a strong family history of melanoma may raise concern in some people.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widespread in the general population. Most do not directly affect health and simply reflect the natural differences seen among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-studied variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When vulvar melanoma has spread or comes back after surgery, the next treatment choice often depends on the genetic changes found in the tumor itself. In vulvar melanoma, doctors may test the cancer for changes such as KIT, and less often BRAF or NRAS, because these results can help show whether a targeted drug is worth considering. This kind of genetic testing for vulvar melanoma treatment looks at changes in the cancer cells, not usually the genes you were born with. Genetics is only one factor, so treatment decisions also depend on where the cancer is, how fast it is growing, and whether options like immunotherapy are likely to help. In some cases, a person’s own genes can also affect how their body handles certain medicines, which may influence side effects or dosing, but this is usually a smaller part of care than the tumor’s genetic profile.
Interactions with other conditions
Changes in the vulva from vulvar melanoma can sometimes be mistaken for more common problems such as lichen sclerosus, eczema, yeast infections, or harmless moles, which may delay care. This matters because early symptoms of vulvar melanoma can look subtle at first, such as itching, bleeding, a dark spot that changes, or a sore that does not heal. Doctors call it a comorbidity when two conditions occur together, and having another vulvar skin condition at the same time can make symptoms harder to sort out. People with weakened immune systems or a history of melanoma elsewhere on the body may need especially careful follow-up, since these factors can affect overall cancer risk and monitoring. Vulvar melanoma itself does not usually cause other diseases directly, but it can overlap with other health issues that affect healing, treatment choices, and how quickly changes are noticed.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Vulvar melanoma?
Symptoms that can look like vulvar melanoma include harmless moles or dark skin spots, skin irritation such as eczema, long-lasting vulvar skin conditions like lichen sclerosus, cysts, genital warts, or infections that cause itching, pain, or bleeding. Some other vulvar cancers can also look similar, especially if there is a new lump, a sore that does not heal, or a spot that changes color or size. Because these problems can overlap, a new or changing vulvar spot should be checked by a doctor.
History
For much of medical history, dark or changing spots on the vulva were difficult to interpret. Some were harmless, while others were signs of a serious cancer, and without modern microscopes or imaging, doctors often could not tell the difference early on. That meant many people living with vulvar melanoma were diagnosed only after symptoms such as bleeding, itching, pain, or a lump had already become hard to ignore.
Early reports described unusual pigmented growths in the genital area, but these cases were often grouped with other skin cancers or with noncancerous vulvar conditions. Once considered rare, now recognized as a distinct form of melanoma, vulvar melanoma gradually became better understood as pathology improved in the 1800s and 1900s. As doctors learned to examine tissue more closely, they became better at separating this disease from more common vulvar problems.
During the 20th century, surgeons and pathologists began to document patterns more carefully, including where these tumors tend to appear and how deeply they grow into nearby tissue. This mattered because depth of growth was linked to outcome, helping guide treatment and prognosis. For many, this changed care from a one-size-fits-all approach to a more tailored plan based on the tumor’s features.
Over time, researchers also recognized that vulvar melanoma is not simply the same as melanoma on sun-exposed skin. That helped explain why prevention, behavior, and treatment patterns can differ. In recent decades, awareness has grown that early symptoms of vulvar melanoma can be subtle: a new dark spot, a patch that changes color, ongoing irritation, or a small area that bleeds when touched may be easy to dismiss at first, especially in a private part of the body many people do not examine closely.
Modern care has continued to evolve. Better biopsy techniques, more detailed pathology reports, and advances in imaging have improved diagnosis and staging, while treatment has moved toward balancing cancer control with quality of life whenever possible. Researchers later identified a genetic cause in some melanomas more broadly, but the history of vulvar melanoma has shown that careful examination and timely biopsy remain central. Knowing this history helps explain why prompt evaluation of persistent vulvar changes is still so important today.